Panacea Biotech Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results    (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,6769511,1861,139293248210555 
Other income Rs m1273333411111812 
Turnover Rs m1,8029841,2191,180304260218567 
Expenses Rs m1,4611,1351,2899651,406373528474 
Gross profit Rs m21523-5781732,495-125-47282 
Depreciation Rs m13813713613684716865 
Interest Rs m25726126828223541317 
Profit before tax Rs m-53-342-948-2042,187-188-54511 
Tax Rs m3227272726262423 
Profit after tax Rs m-86-368-975-2302,161-214-569-13 
Gross profit margin %12.82.4-48.715.2852.7-50.2-225.114.7 
Effective tax rate %-60.7-7.8-2.8-13.11.2-13.6-4.4220.0 
Net profit margin %-5.1-38.7-82.2-20.2738.4-86.1-271.4-2.3 
Diluted EPS Rs -1.4 -6.0 -15.9 -3.8 35.3 -3.5 -9.3 -0.2  
Diluted EPS (TTM) Rs -11.7 -9.9 -24.9 -27.1 9.6 12.1 18.7 22.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Panacea Biotech 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare PANACEA BIOTECH With:   AJANTA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Fell 540 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red.

Views on news

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About (Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Oct 26, 2020 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - TTK HEALTHCARE COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS